SCHEMBL8470906

SCHEMBL8470906

CC(C)c1cccc2c1SCC(C(=O)C(F)(F)F)C2=O

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.33
ANPEP P15144 2/20 0.33
PTPN5 P54829 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HBB P68871 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8470926 0.73
SCHEMBL8470418 0.69 KDM4E (0.41) ALDH1A1
SCHEMBL8473048 0.66 KDM4E (0.36)
SCHEMBL12230909 0.64 NOTUM (0.41)
SCHEMBL12276560 0.64 ACHE (0.36)
SCHEMBL8472988 0.64 KDM4E (0.43) ALDH1A1
SCHEMBL30308326 0.64 TDP1 (0.39) ALDH1A1HSD17B10
SCHEMBL29515448 0.64 TDP1 (0.35) ALDH1A1
SCHEMBL8473139 0.64 KDM4E (0.36) DPP4ANPEPNR1H2NR1H3ALDH1A1
SCHEMBL6352009 0.61 ACHE (0.47) ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5886016-A ANTIINFLAMMATORY AGENT WITH MINIMAL SIDE EFFECTS FOR TREATING ARTHRITIS G.D. SEARLE & CO. (US) 1999-03-23 US disclosed
US-5670532-A Pyrazolyl derivatives for the treatment of inflammation G. D. SEARLE & CO. (US) 1997-09-23 US disclosed
US-5565482-A ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS G.D. SEARLE & CO. (US) 1996-10-15 US disclosed
US-5547975-A ANTIARTHRIC AGENTS, ANALGESICS AND ANTIPYRETICS; INHIBITORS OF CYCLOOXYGENASE II; SIDE EFFECT REDUCTION G.D. SEARLE & CO. 1996-08-20 US disclosed
WO-1996009304-A1 BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-28 WO disclosed